Date: 09 Jun 2017 (Friday)

Archive

HKBU to announce trial results on Tianjiu therapy for hay fever on Tuesday

浸會大學下周二發佈天灸治療鼻敏感臨床研究結果

Allergic rhinitis, commonly known as hay fever, is an inflammation of the nose and eyes which occurs when the immune system overreacts to allergens in the air such as pollen, pet hair, dust and mould. The typical symptoms include a runny or blocked nose, sneezing, itchy and watery eyes, and swelling around the eyes. Currently, around 10-20% of the world’s population suffers from allergic rhinitis. Patients usually receive routine symptomatic pharmacotherapies, or immunotherapy, depending on their health condition. However, these treatments do not obtain satisfactory results, as only one third of adult patients experience satisfactory relief. It is also difficult to determine the optimal use, the appropriate initiation timing and proper duration of the immunotherapy treatment.

From the perspective of Chinese medicine, allergic rhinitis is mainly caused by the attack of exogenous evils, deficiency of organs and an abnormal body institution. Both internal and external Chinese medicine treatments are concurrently used to treat this disease, one of which is called Tianjiu therapy.

Tianjiu therapy is also known as “herbal moxibustion” or “acupoint herbal patching”, and has a long history in treating multiple respiratory diseases such as asthma, chronic bronchitis and chronic obstructive pulmonary disease. It helps to regulate the functions of meridians and organs, and to invigorate the physical institution.
   
To evaluate the efficacy and safety of Tianjiu therapy for treating allergic rhinitis, the School of Chinese Medicine (SCM) of Hong Kong Baptist University (HKBU) recently conducted a clinical trial with Tianjiu therapy. HKBU’s Research Assistant Professor of the SCM Clinical Division, Dr Zhong Lidan, will announce the findings on Tuesday. Details of the session are as follows:

Date:    13 June 2017 (Tuesday)
Time:    11am
Venue:  SCM 809, 8/F Jockey Club School of Chinese Medicine Building
            HKBU Baptist University Road campus (new campus)
            7 Baptist University Road, Kowloon Tong
Language: Cantonese

You are cordially invited to send reporters/photographers to cover the above event. For media enquiries, please contact Jasmine Lau of HKBU Communication and Public Relations Office at 3411 7828 or 7472 2122.

~ END ~


鼻敏感是由炎症性過敏反應所引起的眼部和鼻部的一系列症狀,主要成因多由於吸入過敏原等所致,典型症狀包括流涕、打噴嚏、鼻塞、鼻癢等。現時鼻敏感患者人數約佔全球人口的百分之十至二十。視乎患者的身體狀況,鼻敏感患者一般會接受常規對症或免疫療法,但治療效果往往未如理想,僅有三分之一的成人患者經過治療後得到有效緩解,而免疫療法的最佳使用時機、起始用藥時間和療程均難以確定。

在中醫學角度來說,鼻敏感是由外邪侵襲、臟腑虧虛和體質偏頗,而導致的過敏性鼻炎。中醫治療鼻敏感多以內服與外用兼行,其中包括天灸療法。天灸療法亦稱作「草藥敷貼」或「穴位敷貼」,適用於治療長期呼吸系統疾病,如哮喘、慢性支氣管炎、慢性阻塞性肺病等,以及調節臟腑經絡功能及扶正抗邪。
   
香港浸會大學中醫藥學院最近進行了一項天灸治療鼻敏感──隨機雙盲安慰劑對照的臨床研究,以評估天灸療法對治療過敏性鼻炎實際症狀的療效與安全性。參與項目的中醫藥學院臨床部研究助理教授鍾麗丹博士將於下周二發佈研究所得,分享會詳情如下:
   
日期:2017年6月13日 (星期二)
時間:上午11時   
地點:九龍塘浸會大學道7號浸大浸會大學道校園 (新校)
         賽馬會中醫藥學院大樓8樓SCM 809室
語言:廣東話

歡迎 貴機構派員訪攝上述活動。傳媒查詢:浸會大學傳訊公關處劉子瑩 (3411 7828或7472 2122)。
   
~ 完 ~
Press Contacts 傳媒聯絡:

Jasmine Lau

Communication and Public Relations Office

3411 7828 or 7472 2122

劉子瑩

傳訊公關處

3411 7828 or 7472 2122